AstraZeneca e-mails show debate on Seroquel risks

Marketing executives at British drugmaker AstraZeneca P.L.C. for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.

Copyright PHILY - Philly.com
Exit mobile version